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Background: Inhibition of mitochondrial Na+/Ca2+ exchanger has been recently recognized as a novel therapeutic target for the prevention of 
arrhythmias in heart failure. We examined the effects of CGP-37157, an inhibitor of the mitochondrial Na+/Ca2+ exchanger, administered at the 
onset of reperfusion, on infarct size and microvascular integrity in a porcine model of ischemia-reperfusion.
methods: Acute myocardial infarction was induced in 18 pigs (weight 30-35kg) by ligation of the mid left anterior descending coronary artery for 
60 minutes, followed by 2 hours of reperfusion. At 60 minutes of ischemia and before the onset of reperfusion, the animals were randomly assigned 
(1-1) to either intracoronary infusion of CGP or normal saline. At the end of the experiment, the infarct size (as a percentage of the myocardial area 
at risk) as well as the area of the hemorrhagic infarct were measured.
results: : The myocardial area at risk was similar in both groups (28.82 ± 5.84 vs 28.12± 8.1, P=0.838 respectively ). Infarct size did not differ 
between treated and control animal (74.94 ± 13% vs 79.45± 9.9% respectively, P = 0.42). There was a reduction of the hemorrhagic infarct in CGP 
treated animals, however the difference did not reach statistical significance (7.46 ± 6.2% vs 17.3± 18.9%, respectively, P = 0.17). ST resolution 
was faster in CGP-37157 treated animals (complete resolution within 30 minutes in 100% vs 0% in control animals).
conclusion: In a preclinical model of acute myocardial infarction, intracoronary administration of CGP-37157, an inhibitor of the mitochondrial 
Na+/Ca2+ exchanger, did not confer any cardioprotective effect in terms of infarct size reduction; however it expedited ST resolution towards normal 
and showed a trend for reduction of hemorrhagic infarct.
